Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 19.74M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -15.96M | Forward P/E | -0.47 | EPS next Y | - | 50D Avg Chg | 9.00% |
| Sales | 481k | PEG | - | EPS past 5Y | - | 200D Avg Chg | 57.00% |
| Dividend | N/A | Price/Book | 0.98 | EPS next 5Y | - | 52W High Chg | -12.00% |
| Recommedations | 3.00 | Quick Ratio | 4.58 | Shares Outstanding | 77.64M | 52W Low Chg | 177.00% |
| Insider Own | 13.48% | ROA | -29.12% | Shares Float | 57.68M | Beta | 0.71 |
| Inst Own | 14.05% | ROE | -59.52% | Shares Shorted/Prior | 250.34K/296.72K | Price | 0.28 |
| Gross Margin | 96.47% | Profit Margin | - | Avg. Volume | 1,393,614 | Target Price | - |
| Oper. Margin | -3,388.57% | Earnings Date | Mar 12 | Volume | 951,626 | Change | -6.60% |
About Vascular Biogenics Ltd.
Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. It develops VB-601 using monocyte targeting technology for various inflammatory indications. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.